1.
Clin Infect Dis
; 73(7): 1292-1295, 2021 10 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34037753
RESUMO
We evaluated the gut resistome of children from communities treated with 10 twice-yearly azithromycin distributions. Although the macrolide resistance remained higher in the azithromycin arm, the selection of non-macrolide resistance observed at earlier time points did not persist. Longitudinal resistance monitoring should be a critical component of mass distribution programs. CLINICAL TRIALS REGISTRATION: NCT02047981.